Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients

NCT04512430 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Low recruitment

Conditions

Non Small Cell Lung Cancer
EGFR Gene Mutation

Interventions

DRUG: Atezolizumab
DRUG: Bevacizumab
DRUG: Carboplatin
DRUG: Pemetrexed

Sponsor

Fundación GECP